Product
JZP-258
Aliases
XYWAV
1 clinical trial
1 indication
Indication
NarcolepsyClinical trial
A Phase 4 Multicenter, Open-label, Single-arm Study of Safety, Tolerability, Effectiveness and Treatment Optimization in Participants Switching From Xyrem to XYWAV for the Treatment of NarcolepsyStatus: Completed, Estimated PCD: 2022-11-15